U.S. Pharmaceuticals & Biotech Most Popular Stocks

Medpace Holdings

Market Cap: US$16.1b

Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.

BridgeBio Pharma

Market Cap: US$16.0b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

Exelixis

Market Cap: US$14.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Elanco Animal Health

Market Cap: US$12.8b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Arrowhead Pharmaceuticals

Market Cap: US$12.7b

Develops medicines for the treatment of intractable diseases in the United States.

Revvity

Market Cap: US$12.4b

Provides health sciences solutions, technologies, and services.

ICON

Market Cap: US$12.1b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Corcept Therapeutics

Market Cap: US$11.9b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.7b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Madrigal Pharmaceuticals

Market Cap: US$11.7b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

Charles River Laboratories International

Market Cap: US$11.3b

Charles River Laboratories International, Inc.

Bio-Techne

Market Cap: US$11.2b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Summit Therapeutics

Market Cap: US$11.0b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Axsome Therapeutics

Market Cap: US$11.0b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Cytokinetics

Market Cap: US$10.7b

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States.

Apogee Therapeutics

Market Cap: US$10.1b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophagitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications in the United States.

Halozyme Therapeutics

Market Cap: US$9.9b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

Krystal Biotech

Market Cap: US$9.6b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Avantor

Market Cap: US$9.3b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Spyre Therapeutics

Market Cap: US$9.2b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases.

Ionis Pharmaceuticals

Market Cap: US$9.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Bio-Rad Laboratories

Market Cap: US$8.9b

Develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Crinetics Pharmaceuticals

Market Cap: US$8.9b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Qiagen

Market Cap: US$8.8b

Provides sample to insight solutions that transform biological samples into molecular insights worldwide.

Protagonist Therapeutics

Market Cap: US$8.7b

Operates as a discovery and development company in the United States.

Kymera Therapeutics

Market Cap: US$8.7b

A clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system.

Praxis Precision Medicines

Market Cap: US$8.6b

A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.

Tempus AI

Market Cap: US$8.5b

Operates as a healthcare technology company in the United States.

Repligen

Market Cap: US$8.5b

A life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Alkermes

Market Cap: US$8.3b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Hisamitsu Pharmaceutical

Market Cap: US$8.2b

Manufactures and sells pharmaceuticals in Japan.

Immunovant

Market Cap: US$8.1b

A clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases.

Vaxcyte

Market Cap: US$7.9b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Liquidia

Market Cap: US$7.9b

A biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.

ImmunityBio

Market Cap: US$7.7b

A biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases.

Bruker

Market Cap: US$7.7b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.